Scarlet assesses artificial intelligence medical devices and medical software for compliance with applicable regulatory requirements.
Scarlet has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in October 2026.
Scarlet's investors include Headline, Entrepreneurs First, Creandum, Kindred Capital, Atomico.
Scarlet is headquartered in London, United Kingdom.
Scarlet assesses artificial intelligence medical devices and medical software for compliance with applicable regulatory requirements.
Scarlet is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scarlet — Funding & Investors." VCBacked, October 12, 2026, https://www.vcbacked.co/company/scarlet. Accessed November 12, 2026.
VCBacked. (2026). Scarlet — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/scarlet
{{cite web |title=Scarlet — Funding & Investors |url=https://www.vcbacked.co/company/scarlet |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Scarlet? Request a listing update